Abstract
A number of distinct viruses are known as hemorrhagic fever viruses based on a shared ability to induce hemorrhage by poorly understood mechanisms, typically involving the formation of blood clots (“disseminated intravascular coagulation”). It is well documented that selenium plays a significant role in the regulation of blood clotting via its effects on the thromboxane/prostacyclin ratio, and effects on the complement system. Selenium has an anticlotting effect, whereas selenium deficiency has a proclotting or thrombotic effect. It is also well documented that extreme dietary selenium deficiency, which is almost never seen in humans, has been associated with hemorrhagic effects in animals. Thus, the possibility that viral selenoprotein synthesis might contribute to hemorrhagic symptoms merits further consideration. Computational genomic analysis of certain hemorrhagic fever viruses reveals the presence of potential protein coding regions (PPCRs) containing large numbers of in-frame UGA codons, particularly in the −1 reading frame. In some cases, these clusterings of UGA codons are very unlikely to have arisen by chance, suggesting that these UGAs may have some function other than being a stop codon, such as encoding selenocysteine. For this to be possible, a downstream selenocysteine insertion element (SECIS) is required. Ebola Zaire, the most notorious hemorrhagic fever virus, has a PPCR with 17 UGA codons, and several potential SECIS elements can be identified in the viral genome. One potential viral selenoprotein may contain up to 16 selenium atoms per molecule. Biosynthesis of this protein could impose an unprecedented selenium demand on the host, potentially leading to severe lipid peroxidation and cell membrane destruction, and contributing to hemorrhagic symptoms. Alternatively, even in the absence of programmed selenoprotein synthesis, it is possible that random slippage errors would lead to increased encounters with UGA codons in overlapping reading frames, and thus potentially to nonspecific depletion of SeC in the host.
Similar content being viewed by others
References
G. Andrei and E. De Clercq,Antiviral Res. 22, 45–75 (1993).
F. A. Murphy, M. P. Kiley, and S. P. Fisher-Hoch, inVirology, B. N. Fields and D. M. Knipe, eds., Raven, New York, pp. 933–942 (1990).
G. A. Martini and R. A. Siegert, inMarburg Virus Disease, Springer, pp. 1–230 (1971).
K. M. Johnson, J. V. Lange, P. A. Webb, and F. A. Murphy,Lancet,1, 569–571 (1977).
K. G. Ishak, D. H. Walker, J. A. W. Coetzer, J. J. Gardner, and L. Forelkin,Prog. Liver Dis.,3, 495–515 (1982).
M. Bachofen and E. R. Weibel,Chest 65, 14–19 (1974).
B. F. Trump, J. M. Valigorsky, R. T. Jones, W. J. Mergner, J. H. Garcia, and R. A. Cowley,Hum. Pathol. 6, 499–516 (1975).
H. Schnittler, F. Mahner, D. Drenckhahn, H. Klenk, and H. Feldmann,J. Clin. Invest. 91, 1301–1309 (1993).
M. N. Pensiero, J. B. Sharefkin, C. W. Dieffenbach, and J. Hay,J. Virol. 66, 5929–5936 (1992).
R. D. Davenport, T. J. Polak, and S. L. Kunkel,Transfusion 34, 943–949 (1994).
S. Thien, J. Aaskov, T. T. Myint, T. N. Shwe, T. T. Saw, and A. Zaw,J. Med. Virol. 40, 102–106 (1993).
S. P. Fisher-Hoch, G. S. Platt, G. H. Neild, T. Southee, A. Baskerville, R. T. Raymond, G. Lloyd, and D. I. H. Simpson,J. Infect. Dis 152, 887–894 (1985).
M. M. Ricetti, G. C. Guidi, G. Bellisola, R. Marocchella, A. Rigo, and G. Perona,Biol. Trace. Element Res. 46, 113–123 (1994).
M. Meydani,Biol. Trace. Element Res 33, 79–86 (1992).
R. I. Levin, B. B. Weksler, A. J. Marcus, and E. A. Jaffe, inBiology of Endothelial Cells E. A. Jaffe, ed., Martinus Nijhoff Publishers, Boston, pp. 228–247 (1984).
A. J. Marcus, M. J. Broekman, B. B. Weksler, E. A. Jaffe, L. B. Safier, H. L. Ullman, N. Islam, and K. Tack-Goldman,Ann. NY Acad. Sci. 40, 195–202 (1982).
S. Moncada,Br. J. Pharmacol. 76, 3–31 (1982).
J. B. Smith,Am. J. Pathol. 99, 743–804 (1980).
M. Hamberg, J. Svensson, and B. Samuelsson,Proc. Natl. Acad. Sci. USA 72, 2994–2998 (1975).
R. Schiavon, G. E. Freeman, G. C. Gundi, G. Perona, M. Zatti, and V. V. Kakkar,Thromb. Res. 34, 389–396 (1984).
N. W. Schoene, V. C. Morris, and O. A. Levander,Nutr. Res. 6, 75 (1986).
M. L. Eskew, A. Zarkower, W. J. Scheuchenzuber, G. R. Hildenbrandt, R. W. Scholz, and C. C. Reddy,Prostaglandins,46, 319–329 (1993).
G. Perona, R. Schiavon, G. C. Guidi, D. Veneri, and P. Minuz,Thromb. Halmost. 64, 312 (1990).
J. Feng, Z. G. Feng, and D. J. Wang,Acta Veterinaria et Zootechnica Sinica 18, 249–255 (1987).
Y. Takahashi, H. Kanai, M. Itagaki, A. Noro, and K. Omi,J. Jpn. Vet. Med. Assoc. 48, 71–74 (1995).
S. Hassan, J. Hakkarainen, L. Jonsson, and J. Tyopponen,J. Vet. Med. Ser. A,37, 708–720 (1990).
A. D. Row, C. G. Gee, A. R. B. Jackson, E. Hall, and P. L. Greentree,Aust. Vet. J. 66, 361–363 (1989).
K. Stoimenov, I. Petrov, K. Khristov, G. Gerasimov, and K. Hristov,Veterinarna-sbirka 87, 31 (1989).
M. Steen, A. Frank, M. Bergsten, and C. Rehbinder,Svensk-Veterinartidning,41, 73–77 (1989).
J. Hou, Z. Jiang, Z. He, Y. Ling, Y. Sun, and T. Xu,Zhangua Yiue Zazhi 73, 645–646 (1993).
E. W. Taylor, R. G. Nadimpalli, and C. S. Ramanathan, Geonomic structures of viral agents in relation to the biosynthesis of selenoproteins,Biol. Trace Element Res. This vol. (1997).
E. W. Taylor and C. S. Ramanathan.,J. Orthomolecular Med. 10, 131–138 (1996).
B. K. Rima,Biochem. Soc. Trans. 24, 1–13 (1996).
E. W. Taylor, C. S. Ramanathan, R. K. Jalluri, and R. G. Nadimpalli,J. Med. Chem. 37, 2637–2654 (1994).
J. R. Wyatt and I. Tinoco, inThe RNA World, R. F. Gesteland, and J. Atkins, eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 465–496 (1993).
M. J. Berry and P. R. Larsen,Biochem. Soc. Trans. 21, 827–32 (1993).
E. W. Taylor, C. S. Ramanathan, R. G. Nadimpalli, and R. F. Schinazi,Antiviral Res. 26, A271, #86.
E. W. Taylor, C. S. Ramanathan, and R. G. Nadimpalli, in M. Witten, ed.,Computational Medicine, Public Health and Biotechnology: Building a Man in the Machine Part 1, World Scientific, London, pp. 285–309 (1996).
G. N. Schrauzer and J. Sacher,Chem.-Biol. Interact. 91, 199–205 (1994).
M. A. Beck, Q. Shi, V. C. Morris, and O. A. Levander,Nature Med. 1, 433–436 (1995).
E. W. Taylor,Biol. Trace Element Res. 49, 85–95 (1995).
M. Zuker and P. Steigler,Nucleic Acids Res. 9, 133–148 (1981).
K. K. McCaughan, C. M. Brown, M. E. Dalphin, M. J. Berry, and W. P. Tate,Proc. Natl. Acad. Sci. USA 92, 5431–5435 (1995).
A. Sanchez, S. G. Trappier, B. W. J. Mahy, C. J. Peters, and S. T. Nichol,Proc. Natl. Acad. Sci. USA 93, 3602–3607.
B. Cubitt, C. Oldstone, J. Valcarcel, and J. C. de la Torre,Virus Res. 34, 69–79 (1994).
C. Vanhee-Brossollett, H. Thoreau, N. Serpente, L. D’Auriol, J.-P. Levy, and C. Vaquero,Virology 206, 196–202 (1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramanathan, C.S., Taylor, E.W. Computational genomic analysis of hemorrhagic fever viruses. Biol Trace Elem Res 56, 93–106 (1997). https://doi.org/10.1007/BF02778985
Issue Date:
DOI: https://doi.org/10.1007/BF02778985